(NASDAQ:OPK), First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced the initiation and recent dosing of the first […]
SAN FRANCISCO, Oct. 28, 2025 (GLOBE NEWSWIRE) — Voltus, Inc. (“Voltus”), the leading virtual power plant (VPP) operator and distributed energy resource (DER) platform, today announced the promotion of Adam Scarsella to Vice President of Digital Infrastructure Sales. In this role, Scarsella will lead Voltus's commercial strategy for data centers and cryptocurrency operations while driving
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) — Obra Capital, Inc. (“Obra”), an asset management firm with a specialized approach to alternative investing, today announced that Melissa Randall has joined the firm as Chief Human Resources Officer and Senior Managing Director. In this role, she will lead Obra's human resources operations, providing talent management and
(NasdaqGM:OBIO),(TSE:4543.T),(TSE:4543), New agreement grants Terumo Virtue SAB coronary indication right of first refusal and supersedes prior distribution agreement Terumo to pay a total of $30 million to Orchestra BioMed Orchestra BioMed retains all development and distribution rights to Virtue SAB in all indications Orchestra BioMed recently initiated patient enrollment for the Virtue Trial, its U.S.
(Madrid:ORY.MC),(Boerse Stuttgart – Freiverkehr:ORN),(Madrid:ORY),(Boerse Stuttgart – Freiverkehr:ORN.SG), To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programs To bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, BME: ORY), a clinical-stage biopharmaceutical company and global
(NASDAQ:SLE), ~ With Offering Over-Subscribed, Company Completes Financing at the Maximum Offering Amount ~ SANTA MONICA, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Super League (Nasdaq: SLE) (the “Company”), a leader in playable media trusted by global brands to reach and activate gaming audiences through playable ads and gamified content, today announces the final closing
MURRAY, Utah, Oct. 28, 2025 (GLOBE NEWSWIRE) — R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the appointment of Estelle Barnes as the leader of R1's Enterprise Customer Engagement and Partnership function. In this role, Ms. Barnes will spearhead R1's efforts to elevate client success, strengthen financial performance, and deepen
MONTRÉAL and RICHMOND, Ky., Oct. 28, 2025 (GLOBE NEWSWIRE) — Novacap, a leading North American private equity firm, is pleased to announce it has entered into a partnership with TAG Towers (“TAG”), a Kentucky-based developer and operator of wireless tower infrastructure. TAG is the fifth platform investment by Novacap's Digital Infrastructure sector. Founded in 2008
(NYSE:TROX), LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Tronox Holdings plc (“Tronox” or “the Company”) (NYSE: TROX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
(NASDAQ:LFVN), SALT LAKE CITY, Oct. 28, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation(R) (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the successful conclusion of Momentum Academy 2025, a dynamic, high-impact event that brought together thousands of Consultants from across the U.S.